Evoke Pharma Inc (EVOK)

4.90 -0.06 (-1.21%) USD  |  NASDAQ  |  Dec 24, 16:00
More

Evoke Pharma Cash and Short Term Investments (Quarterly): 11.34M for Sept. 30, 2024

Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for EVOK.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Cash and Short Term Investments Definition

View Cash and Short Term Investments Definition
Start Trial

Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Eli Lilly and Co 3.518B
MEI Pharma Inc 26.90M
Revance Therapeutics Inc 184.08M
NovaBay Pharmaceuticals Inc 0.776M
Palatin Technologies Inc 2.384M